| Lightcalls.com |
|
|
![]() |
Thirty-six million women in the Uni...Thirty-six million women in the United States have already experienced "the change," or menopause. With herculean leaps in life expectancy from one side of to the other the course of this hundred menopause no longer signals the start of ancient age, but rather the start of a recent era. The average American woman lives a third of her life after menopause, which usually begins at about age 50 However, it is not rare for pre-menopausal symptoms to start occurring, with increasing oftenness about seven to 10 years before. Medically, menopause is caused as the ovaries, from one side of to the other time, produce less and les estrogen Without estrogen to stimulate ovulation, the menstrual periods cease. Many women are relieved to descry the end of monthly bloating, irritability, and other symptoms of premenstrual syndrome that follow pack-and-parcel with the menstrual revolution of time In turn, the natural proces of menopause also ensues with its share of symptoms. Each woman will experience menopause slightly differently. near are plagued with a merry-go-round of choleric flashes, headaches, muscle aches, weight gain, humor swings, vaginal dryness, and hair loss; while a not many may scarcely notice the transition. Hormone replacement therapy v phytoestrogen therapy Many women are pertain toed with good reason, about the health risks of hormone replacement therapy (HRT) the commonly prescribed treatment for easing menopausal symptoms. Consequently sole about 30 percent of menopausal women pick out to take estrogen. Other women may want to use HRT moreover have medical conditions that are incompatible with the hormones, so as unexplained uterine bleeding, liver disease, or past or not past nor future breast cancer. In addition, a certain number of women who may experience extra risks with HRT are those with a history of migraines, gallbladder disease, or uterine cancer. As its name implies, hormone replacement therapy works on increasing the body's estrogen flats with exogenous estrogen. Estrogens from plants work onward this same principle, but without the dangerous side powers of HRT. Natural plant estrogen called phytoestrogens, can fulfill many of the parts of a woman's own estrogen Researchers first became interested in phytoestrogens for menopausal symptom relief after noting that scarcely any Japanese women experience the symptoms synonymous with "American" menopause. Could the lack of menopause symptoms lie in dietary differences between the countries? As it uses out, the typical Japanese diet is extremely high in phytoestrogens from soy (It would appear to be that researchers were on the right track with the diet theory.) To proof the hypothesis, Australian researchers compared the ability of different phytoestrogens to alleviate the symptoms of menopause. A clump of 58 menopausal women, who endureed from 14 or more passionate flashes a week, added united of two types of phytoestrogens to their daily diets for three month At the cessation of the study, the women experienced 25-40 percent fewer excitable flashes as a result of the phytoestrogen supplements Herbal phytoestrogens are a welcome choice One unique plant source of phytoestrogens is black cohosh A standardized extract from the rhizome of Cimicifuga racemosa, the scientific name for black cohosh has been used prosperously for over 40 years in European countries, either as a stand-alone menopause treatment or in conjunction with HRT German scientists, comparing the meanings of several synthetic estrogens with black cohosh extract in 60 women with hysterectomies, which surgically induces menopause, place all of the therapies to be equally effective. This confirms that black cohosh is at least as effective as synthetic estrogen Other research highlights the lack of side imports or risks from supplementing with black cohosh REFERENCES Adlercreutz, H et al. "Dietary Phytoestrogens and the Menopause in Japan," Lancet 339:1233 1992 Duker EM et al. "Effect of Extracts from Cimicifuga racemosa forward Gonadotropin Release in Menopausal Women and Ovariectomized Rats," Planta Medica 57(5):420-424 October 1991 Lehmann-Willenbrock, E et al. "Clinical and Endocrinologic Studies of the Treatment of Ovarian Insufficiency Manifestations Following Hysterectomy with Intact Adnexa," Zentralblatt fur Gynakologie 110(10):611-618 1988 Murkies, A.L. et al. "Dietary Flour Supplementation Decreases Post-menopausal of high temperature Flashes: Effect of Soy and Wheat," Maturitas 21(3):189-195 April 1995 COPYRIGHT 1996 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |